(Q36304030)

13 August 2017

1 reference

title

Primer: an evidence-based approach to prognostic markers (English)

1 reference

13 August 2017

1

Douglas G Altman

1 reference

13 August 2017

Richard D Riley

2

1 reference

13 August 2017

publication date

1 September 2005

1 reference

Nature Clinical Practice Oncology

13 August 2017

published in

1 reference

13 August 2017

volume

2

1 reference

13 August 2017

issue

9

1 reference

13 August 2017

page(s)

466-472

1 reference

Methodological challenges in the evaluation of prognostic factors in breast cancer

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Prognostic molecular markers in early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

c-erbB-2 in breast cancer: development of a clinically useful marker

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Review of survival analyses published in cancer journals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Modelling the effects of standard prognostic factors in node-positive breast cancer. German Breast Cancer Study Group (GBSG)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Missing covariate data within cancer prognostic studies: a review of current reporting and proposed guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Statistical aspects of prognostic factor studies in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Predicting the future: a critical appraisal of cancer prognosis studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Systematic reviews of evaluations of prognostic variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Prognostic factors in non-small cell lung cancer: a decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Is there publication bias in the reporting of cancer risk in Barrett's esophagus?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Sensitivity analyses allowed more appropriate and reliable meta-analysis conclusions for multiple outcomes when missing data was present

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Role of Bcl-2 as a prognostic factor for survival in lung cancer: a systematic review of the literature with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

The pitfalls of narrative reviews in clinical medicine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

p53 immunohistochemistry as a prognostic marker in bladder cancer. Playground for urology scientists?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Establishing a national tissue bank for surgically harvested cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

The International Bladder Cancer Bank: proposal for a new study concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

The strengths and limitations of meta-analyses based on aggregate data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

To IPD or not to IPD? Advantages and disadvantages of systematic reviews using individual patient data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Traditional reviews, meta-analyses and pooled analyses in epidemiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

Prognosis - what does the clinician associate with this notion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

A systematic review and evaluation of the use of tumour markers in paediatric oncology: Ewing's sarcoma and neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Tumor marker utility grading system: a framework to evaluate clinical utility of tumor markers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Tumor markers as clinical cancer tests--are we there yet?

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

REporting recommendations for tumor MARKer prognostic studies (REMARK).

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Evaluating the potential usefulness of new prognostic and predictive indicators in node-negative breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

A guide for reviewing submitted manuscripts (and indications for the design of translational research studies on biomarkers)

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Thymidylate synthase expression and prognosis in colorectal cancer: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

A systematic review of molecular and biological tumor markers in neuroblastoma

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Selective reporting biases in cancer prognostic factor studies

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Systematic Reviews in Health Care

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Dangers of using "optimal" cutpoints in the evaluation of prognostic factors

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

The cooperative prostate cancer tissue resource: a specimen and data resource for cancer researchers

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Dichotomizing continuous predictors in multiple regression: a bad idea

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Publication bias and meta-analyses: a practical example.

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients

1 reference

https://api.crossref.org/works/10.1038%2FNCPONC0287

7 January 2021

Identifiers

DOI

10.1038/NCPONC0287

1 reference

Dimensions Publication ID

13 August 2017

1032430922

0 references

1 reference